Cat. No. 1149
Biological ActivityNeuropeptide with many biological effects including hormone release, stimulation of pancreatic enzyme secretion, inhibition of gastric emptying and modulation of gastric acid secretion.
(Modifications: X-1 = pGlu, Met-13 = C-terminal amide)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Tache et al (1988) Central nervous system action of bombesin to influence gastric secretion and ulceration. Ann.N.Y.Acad.Sci. 547 183. PMID: 3071217.
McCoy and Avery (1990) Bombesin: potential integrative peptide for feeding and satiety. Peptides 11 595. PMID: 2199952.
Battey and Wada (1991) Two distinct subtypes for mammalian bombesin-like peptides. TiNS 14 524. PMID: 1726343.
If you know of a relevant citation for this product please let us know.
Keywords: Bombesin, supplier, Involved, gastrointestinal, tract, function, GRP-Preferring, Receptors, BB1, BB2, BB3, Gastrin-Releasing, Peptide-Preferring, NMB-Preferring, Neuromedin, B-Preferring, Bombesin, agonists
Find multiple products by catalog number
New Products in this Area
Oxytocin analogML 221
Apelin receptor (APJ) antagonistQ94 hydrochloride
Negative allosteric modulator at PAR1 receptorFSLLRY-NH2
PAR2 peptide antagonistSB 611812
Urotensin-II (UT) antagonist; attenuates cardiac dysfunctionTC-MCH 7c
Selective melanin-concentrating hormone receptor 1 (MCH1R) antagonistCYM 9484
Potent NPY Y2 receptor antagonist
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.